Back
Corporate News
AstraZeneca India to review quarterly results at a board meeting on August 10
04-Aug-2026, 12:00
AstraZeneca Pharma India Limited will hold a board meeting on Monday, August 10, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026, the company said in a filing. The trading window for designated persons will remain closed from June 16, 2026, to August 12, 2026, in accordance with the company’s insider trading code.
AstraZeneca Pharma India Limited will hold a board meeting on Monday, August 10, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026, the company said in a filing. The trading window for designated persons will remain closed from June 16, 2026, to August 12, 2026, in accordance with the company’s insider trading code.